News & stories

Anti-MCV – Fill the gap in rheumatoid arthritis diagnosis
This comprehensive meta-analysis highlights the benefit of testing anti-MCV additionally to anti-CCP and RF in the context of early diagnosis of Rheumatoid Arthritis.
Timely Diagnosis of Myeloma in Populations with Comorbidities and Health Disparities: Testing Considerations
Educational Webinar with Joseph Mikhael, MD & Christopher Farnsworth, PhD
Sebia receives U.S. FDA Clearance for the CAPILLARYS 3 DBS devicess
The next generation instrument for screening hemoglobin disorders in newborns.
To see or not A1c? HbA1c utilization in light of recent lab guidelines
Educational Webinar with Dr. Matthew C. Wagner
Unlocking the power of anti-MCV detection for early diagnosis of Rheumatoid Arthritis
Educational Webinar with Holger Bang, PhD & Roberto Fiorillo
Sebia receives U.S. FDA Clearance for the FLC Kappa & Lambda assays
Expanding offering for Multiple Myeloma and AL Amyloidosis Testing.